isoproterenol has been researched along with 3,4-dihydroxyphenyllactic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Huang, L; Le, X; Meng, J; Tang, Y; Wang, M; Wu, P; Yu, P | 1 |
| Bi, LL; Cao, W; Hu, J; Li, H; Miao, S; Qiu, PC; Sun, JY; Wang, JB; Wang, SW; Xie, YH; Yang, Q; Zhang, BL; Zhou, XX | 1 |
| Jia, P; Li, Z; Lu, H; Tian, A; Wu, J; Xing, R; Yang, C; Yang, L; Zhang, Y; Zheng, X | 1 |
| Chen, Y; Dong, QQ; Duan, LR; Li, H; Sheng, JJ; Song, F; Wang, SW; Xie, YH; Yang, Q; Zhang, BL | 1 |
| Bao, Y; Chu, L; Chu, X; Guo, H; Liu, H; Liu, Y; Song, Q; Zhang, J; Zhang, X; Zhang, Y | 1 |
5 other study(ies) available for isoproterenol and 3,4-dihydroxyphenyllactic acid
| Article | Year |
|---|---|
Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Arrhythmias, Cardiac; Cardiomegaly; Cardiotonic Agents; Connexins; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Electrocardiography; Hemodynamics; Isoproterenol; Lactates; Male; Phytotherapy; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Tetrazoles; Valine; Valsartan | 2011 |
Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats.
Topics: Acetophenones; Animals; Antioxidants; bcl-2-Associated X Protein; Biomarkers; Body Weight; Cardiotonic Agents; Caspase 3; Drug Therapy, Combination; Electrocardiography; Glutathione; Immunohistochemistry; Isoproterenol; Lactates; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; NF-E2-Related Factor 2; Organ Size; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Troponin I; Ultrasonography | 2012 |
Danshensu inhibits β-adrenergic receptors-mediated cardiac fibrosis by ROS/p38 MAPK axis.
Topics: Adrenergic beta-Agonists; Animals; Cardiomyopathies; Cell Proliferation; Cells, Cultured; Collagen Type I; Fibroblasts; Fibrosis; Isoproterenol; Lactates; MAP Kinase Signaling System; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Adrenergic, beta | 2014 |
Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: Roles of Nrf2/HO-1 and PI3K/Akt pathway.
Topics: Acetophenones; Animals; Apoptosis; Blotting, Western; Cardiotonic Agents; Creatine Kinase, MB Form; Drug Therapy, Combination; Drugs, Chinese Herbal; Heme Oxygenase-1; Isoproterenol; Lactates; Male; Microscopy, Electron, Transmission; Molecular Structure; Myocardial Infarction; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phytotherapy; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Troponin I; Troponin T | 2016 |
Mechanisms underlying the cardioprotective effect of Salvianic acid A against isoproterenol-induced myocardial ischemia injury in rats: Possible involvement of L-type calcium channels and myocardial contractility.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Electrocardiography; Isoproterenol; L-Lactate Dehydrogenase; Lactates; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Patch-Clamp Techniques; Rats, Sprague-Dawley; Time Factors | 2016 |